Liminatus Pharma, Inc.

LIMNW

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001971387

SEC filings (opens in a new tab)

No open-market purchases or sales by Liminatus Pharma, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $90.1K in total; no superinvestor holds it.

Other share classesLIMN

Q2 2026 vs. Q1 2026

How the institutions holding Liminatus Pharma, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of LIMNW: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Q2 2026	Change
Holders	21	22	+1
Shares	1.59M	1.57M	−14.7K (−0.9%)
Value	$72.6K	$90.1K	+$17.5K (+24.1%)

New holders (2)

Institutions that held Liminatus Pharma, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to LIMNW in Q2 2026
Institution	Shares	Value	% of portfolio
Susquehanna International Group, LLP	17,562	$1.32K	0.00%
Virtu Financial LLC	10,805	$1.00K	0.00%

Sold out (1)

Institutions that held Liminatus Pharma, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of LIMNW in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Clear Street Group Inc.	100	$4